182 related articles for article (PubMed ID: 30541493)
21. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
22. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
[TBL] [Abstract][Full Text] [Related]
23. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
Sutter RW; Prevots DR; Cochi SL
Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
[TBL] [Abstract][Full Text] [Related]
24. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
25. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
[TBL] [Abstract][Full Text] [Related]
26. Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013-2014.
Gali E; Mkanda P; Banda R; Korir C; Bawa S; Warigon C; Abdullahi S; Abba B; Isiaka A; Yahualashet YG; Touray K; Chevez A; Tegegne SG; Nsubuga P; Etsano A; Shuaib F; Vaz RG
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S73-8. PubMed ID: 26908755
[TBL] [Abstract][Full Text] [Related]
27. Profiling the immunity status of children with non-polio acute flaccid paralysis who had not received any doses of oral polio vaccine in the South-South region, Nigeria 2011-2014.
Bassey BE; Vaz RG; Braka F; Komakech W; Maleghemi ST; Akpan GU; Okocha-Ejeko A
Public Health; 2016 Oct; 139():148-153. PubMed ID: 27302057
[TBL] [Abstract][Full Text] [Related]
28. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
[TBL] [Abstract][Full Text] [Related]
29. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
30. Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1150-4. PubMed ID: 19847150
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F;
J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827
[TBL] [Abstract][Full Text] [Related]
32. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
[TBL] [Abstract][Full Text] [Related]
33. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
[TBL] [Abstract][Full Text] [Related]
34. Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.
Lengkat FA; Chukwudozie OS; Vincent OO; James DM; Amina HG; Kenneth O
Pan Afr Med J; 2019; 34():183. PubMed ID: 32158512
[TBL] [Abstract][Full Text] [Related]
35. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):682-5. PubMed ID: 17625496
[TBL] [Abstract][Full Text] [Related]
36. Progress toward poliomyelitis eradication --- Nigeria, January 2010-June 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Aug; 60(31):1053-7. PubMed ID: 21832977
[TBL] [Abstract][Full Text] [Related]
37. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevots DR; Burr RK; Sutter RW; Murphy TV;
MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
[TBL] [Abstract][Full Text] [Related]
38. The CORE Group Partners Project in North East Nigeria: Community Engagement Strategies to Combat Skepticism and Build Trust for Vaccine Acceptance.
Usman S; Bologna L; Stamidis KV
Am J Trop Med Hyg; 2019 Oct; 101(4_Suppl):68-73. PubMed ID: 31760975
[TBL] [Abstract][Full Text] [Related]
39. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
40. Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2013-August 2014.
Farag NH; Alexander J; Hadler S; Quddus A; Durry E; Wadood MZ; Tangermann RH; Ehrhardt D;
MMWR Morb Mortal Wkly Rep; 2014 Oct; 63(43):973-7. PubMed ID: 25356605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
